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LETTER TO THE EDITOR
Blood groups and lung cancer
Sir - The increased incidence of specific malignancies in
patients with certain blood groups is well recognised. For
example, both gastric cancers and salivary tumours are more
common in patients with blood group A (Aird et al., 1953;
Cameron, 1958) and Ashley (1969) demonstrated an
association between the differentiation and site of lung
tumours and particular blood groups.
In the course of a study of various prognostic factors in
malignant lung conditions, we confirmed the findings of
Jakoubkova and Majsky (1965) that there appears to be no
increase in the incidence of lung cancer within any particular
blood group. However, we have observed a distinct
association between blood group and survival following
surgery.
Eighty-six patients who had resection of lung cancers
between 1978 and 1983 (62 squamous cell carcinomas, 20
adenocarcinomas and 4 small cell carcinomas) were studied.
These patients had no evidence of metastatic spread at the
time of operation. The overall frequency of the ABO blood
groups was comparable to that of the normal population
(Race & Sanger, 1975) (A 32%, B 12%, AB 6%, 0 50%)
and the distribution of histological types was similar within
each blood group. Using the Log Rank test we found that
those patients who were blood group B or AB had a
significantly shorter survival following operation than
patients within other blood groups (P=0.0017) (Table I).
The median survival of patients with blood group AB was
14 months; of patients with blood group B, 24 months; of
patients with blood group A greater than 48 months and of
those with blood group 0 greater than 60 months. The
median follow up was 41 months. Median survival in excess
of 60 months initially seemed surprisingly good but these
patients were a highly selected group; all had limited disease
Table I
Number of Observed Expected
Blood group patients deaths deaths
A 28 10 10.94
B 10 7 3.14
AB 5 4 1.09
0 43 11 16.82
and all were operated on by one surgeon (RL). Patients
dying within the first week of surgery were excluded as were
those in whom the cause of death was unknown.
Further analysis revealed no association between survival
and either perioperative blood transfusion or rhesus status.
Detailed analysis of the survival of the various histological
types within each blood group was precluded by the small
numbers involved.
The explanation for the poorer survival of patients whose
blood group is B or AB is unclear, but these findings suggest
that genetic factors may play a role in determining the
prognosis of patients with lung cancer.
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